These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2078487

  • 1. The establishment, characterization and calibration of human ovarian carcinoma xenografts for the evaluation of novel platinum anticancer drugs.
    Harrap KR, Jones M, Siracky J, Pollard LA, Kelland LR.
    Ann Oncol; 1990; 1(1):65-76. PubMed ID: 2078487
    [Abstract] [Full Text] [Related]

  • 2. Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery.
    Kelland LR, Jones M, Abel G, Valenti M, Gwynne J, Harrap KR.
    Cancer Chemother Pharmacol; 1992; 30(1):43-50. PubMed ID: 1586979
    [Abstract] [Full Text] [Related]

  • 3. Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes.
    Hills CA, Kelland LR, Abel G, Siracky J, Wilson AP, Harrap KR.
    Br J Cancer; 1989 Apr; 59(4):527-34. PubMed ID: 2653399
    [Abstract] [Full Text] [Related]

  • 4. Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.
    Jones M, Siracky J, Kelland LR, Harrap KR.
    Br J Cancer; 1993 Jan; 67(1):24-9. PubMed ID: 8427780
    [Abstract] [Full Text] [Related]

  • 5. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR.
    Cancer Res; 1993 Jun 01; 53(11):2581-6. PubMed ID: 8388318
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
    Goddard P, Valenti M, Kelland LR.
    Anticancer Res; 1994 Jun 01; 14(3A):1065-70. PubMed ID: 8074451
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
    Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR.
    Br J Cancer; 1991 Aug 01; 64(2):215-20. PubMed ID: 1892748
    [Abstract] [Full Text] [Related]

  • 10. Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA,JM8).
    Jones AC, Wilson PA, Steel GG.
    Cancer Chemother Pharmacol; 1984 Aug 01; 13(2):109-13. PubMed ID: 6380788
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines.
    Harstrick A, Bokemeyer C, Scharnofkse M, Hapke G, Reile D, Schmoll HJ.
    Cancer Chemother Pharmacol; 1993 Aug 01; 33(1):43-7. PubMed ID: 8269588
    [Abstract] [Full Text] [Related]

  • 15. Preclinical activity of lobaplatin as a single agent and in combination with taxanes for ovarian carcinoma cells.
    Sun X, Lou LG, Sui DH, Wu XH.
    Asian Pac J Cancer Prev; 2014 Aug 01; 15(22):9939-43. PubMed ID: 25520132
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of murine tumour models and their acquired platinum-resistant counterparts in the evaluation of novel platinum antitumour agents: a cautionary note.
    Goddard PM, Valenti MR, Harrap KR.
    Ann Oncol; 1991 Sep 01; 2(8):535-40. PubMed ID: 1793720
    [Abstract] [Full Text] [Related]

  • 18. Secondary screening of platinum compounds in human ovarian cancer xenografts in nude mice.
    Boven E, Nauta MM, Schluper HM, Elferink F, van der Vijgh WJ, Pinedo HM.
    Eur J Cancer Clin Oncol; 1985 Oct 01; 21(10):1253-60. PubMed ID: 4076289
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Platinum coordination complexes which circumvent cisplatin resistance.
    Harrap KR, Kelland LR, Jones M, Goddard PM, Orr RM, Morgan SE, Murrer BA, Abrams MJ, Giandomenico CM, Cobbleigh T.
    Adv Enzyme Regul; 1991 Oct 01; 31():31-43. PubMed ID: 1877393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.